ozempic or tirzepatide GLP-1 drugs such as semaglutide and are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights Ozempic vs. Tirzepatide: Similarities &

Clinical trial data showed patients taking oral Wegovy lost an average of 13.6% of body weight at 71 weeks, while comparable injectable GLP-1 trials have shown average weight loss to be between 15% to 20%

Storage mistakes that make semaglutide expire faster Expiration dates assume proper storage

Retatrutide Switching to or From: Transition Protocols & Dose Conversion Introduction Retatrutide isnt FDA approved yet

The Realistic Timeline Zepbound Before and After: A Clinical Timeline of Realistic Weight Loss Results Does the Zepbound Injection Hurt

The three major risk factors in the development of cataracts are ageing, diabetes and exposure to sunlight [7,8], with ageing considered to be the most prominent [9]